Roth Capital Issues Negative Outlook for CVE:HIV Earnings

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Analysts at Roth Capital reduced their Q4 2025 earnings per share estimates for HIVE Blockchain Technologies in a report released on Thursday, February 13th. Roth Capital analyst D. Aftahi now anticipates that the company will post earnings of ($0.14) per share for the quarter, down from their prior estimate of ($0.10). Roth Capital has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q4 2025 earnings at ($0.14) EPS, Q1 2026 earnings at ($0.14) EPS, Q1 2026 earnings at ($0.14) EPS, Q2 2026 earnings at ($0.03) EPS, Q3 2026 earnings at $0.00 EPS, Q4 2026 earnings at $0.16 EPS, FY2026 earnings at $0.01 EPS, FY2026 earnings at $0.01 EPS, FY2027 earnings at $0.54 EPS, FY2027 earnings at $0.54 EPS, FY2028 earnings at $0.13 EPS and FY2028 earnings at $0.13 EPS.

Several other equities analysts have also commented on the company. Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Tuesday, October 29th. Keefe, Bruyette & Woods raised HIVE Blockchain Technologies to a “moderate buy” rating in a research note on Wednesday, January 8th. Four research analysts have rated the stock with a strong buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Strong Buy”.

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.